Even patients with SEVERE kidney disease seem to benefit from ACE inhibitors

March 2006

Even patients with SEVERE kidney disease seem to benefit from ACE inhibitors.

We know that ACE inhibitors slow the progression of kidney disease in patients with mild to moderate kidney disease...but many prescribers are wary about using them for severe disease.

Researchers are now showing that low-dose benazepril reduces proteinuria AND postpones dialysis or transplant in patients with stage 4 kidney disease. These are patients who have glomerular filtration rates of 15-29 mL/min/1.73 m2.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote